Human Growth Hormone - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB503243682

Publication Date:

March 12, 2024

Pages:

118

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Growth hormone (GH), also known as somatotropin (or as human growth hormone in its human form), is a peptide hormone that stimulates growth, cell reproduction, and cell regeneration in humans and other animals. It is thus important in human development. It is a type of mitogen which is specific only to certain kinds of cells. Growth hormone is a 191-amino acid, single-chain polypeptide that is synthesized, stored, and secreted by somatotropic cells within the lateral wings of the anterior pituitary gland.
The global market for Human Growth Hormone was estimated to be worth US$ 4455.2 million in 2023 and is forecast to a readjusted size of US$ 5645.8 million by 2030 with a CAGR of 3.4% during the forecast period 2024-2030
For industry structure analysis, the Human Growth Hormone industry is very concentrated. These manufacturers ranging from large multinational corporations to small privately owned companies compete in this industry. The top five producers include Novo Nordisk, Pfizer, Eli Lilly, Merck Serono and F. Hoffmann-La Roche, account for more than 80% of the revenue market. Regionally, North America is the biggest production value area of valves, also the leader in the whole Human Growth Hormone industry.
North America occupied 42% of the production market. It is followed by Europe and China, which respectively have around 27% and 16% of the global total industry. Other countries have a small amount of production. Geographically, North America was the largest consumption market in the world, which took about 44.59% of the global consumption volume.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Human Growth Hormone, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Human Growth Hormone by region & country, by Type, and by Application.
The Human Growth Hormone market size, estimations, and forecasts are provided in terms of sales volume (Million IU) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Growth Hormone.
麻豆原创 Segmentation
By Company
Novo Nordisk
Pfizer
Eli Lilly
Merck Serono
F. Hoffmann-La Roche
Ferring Pharmaceuticals
GeneScience Pharmaceuticals
Ipsen
LG Life Sciences
Sandoz International
Anhui Anke Biotechnology
Segment by Type:
Powder
Solvent
Segment by Application
Growth Hormone Deficiency (GHD)
Turner Syndrome
Chronic Renal Insufficiency
Prader Willi Syndrome
Small for Gestational Age
SHOX Deficiency
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Human Growth Hormone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Human Growth Hormone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Human Growth Hormone in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Human Growth Hormone Product Introduction
1.2 Global Human Growth Hormone 麻豆原创 Size Forecast
1.2.1 Global Human Growth Hormone Sales Value (2019-2030)
1.2.2 Global Human Growth Hormone Sales Volume (2019-2030)
1.2.3 Global Human Growth Hormone Sales Price (2019-2030)
1.3 Human Growth Hormone 麻豆原创 Trends & Drivers
1.3.1 Human Growth Hormone Industry Trends
1.3.2 Human Growth Hormone 麻豆原创 Drivers & Opportunity
1.3.3 Human Growth Hormone 麻豆原创 Challenges
1.3.4 Human Growth Hormone 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Human Growth Hormone Players Revenue Ranking (2023)
2.2 Global Human Growth Hormone Revenue by Company (2019-2024)
2.3 Global Human Growth Hormone Players Sales Volume Ranking (2023)
2.4 Global Human Growth Hormone Sales Volume by Company Players (2019-2024)
2.5 Global Human Growth Hormone Average Price by Company (2019-2024)
2.6 Key Manufacturers Human Growth Hormone Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Human Growth Hormone Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Human Growth Hormone
2.9 Human Growth Hormone 麻豆原创 Competitive Analysis
2.9.1 Human Growth Hormone 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Human Growth Hormone Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Growth Hormone as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Powder
3.1.2 Solvent
3.2 Global Human Growth Hormone Sales Value by Type
3.2.1 Global Human Growth Hormone Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Human Growth Hormone Sales Value, by Type (2019-2030)
3.2.3 Global Human Growth Hormone Sales Value, by Type (%) (2019-2030)
3.3 Global Human Growth Hormone Sales Volume by Type
3.3.1 Global Human Growth Hormone Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Human Growth Hormone Sales Volume, by Type (2019-2030)
3.3.3 Global Human Growth Hormone Sales Volume, by Type (%) (2019-2030)
3.4 Global Human Growth Hormone Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Growth Hormone Deficiency (GHD)
4.1.2 Turner Syndrome
4.1.3 Chronic Renal Insufficiency
4.1.4 Prader Willi Syndrome
4.1.5 Small for Gestational Age
4.1.6 SHOX Deficiency
4.1.7 Others
4.2 Global Human Growth Hormone Sales Value by Application
4.2.1 Global Human Growth Hormone Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Human Growth Hormone Sales Value, by Application (2019-2030)
4.2.3 Global Human Growth Hormone Sales Value, by Application (%) (2019-2030)
4.3 Global Human Growth Hormone Sales Volume by Application
4.3.1 Global Human Growth Hormone Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Human Growth Hormone Sales Volume, by Application (2019-2030)
4.3.3 Global Human Growth Hormone Sales Volume, by Application (%) (2019-2030)
4.4 Global Human Growth Hormone Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Human Growth Hormone Sales Value by Region
5.1.1 Global Human Growth Hormone Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Human Growth Hormone Sales Value by Region (2019-2024)
5.1.3 Global Human Growth Hormone Sales Value by Region (2025-2030)
5.1.4 Global Human Growth Hormone Sales Value by Region (%), (2019-2030)
5.2 Global Human Growth Hormone Sales Volume by Region
5.2.1 Global Human Growth Hormone Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Human Growth Hormone Sales Volume by Region (2019-2024)
5.2.3 Global Human Growth Hormone Sales Volume by Region (2025-2030)
5.2.4 Global Human Growth Hormone Sales Volume by Region (%), (2019-2030)
5.3 Global Human Growth Hormone Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Human Growth Hormone Sales Value, 2019-2030
5.4.2 North America Human Growth Hormone Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Human Growth Hormone Sales Value, 2019-2030
5.5.2 Europe Human Growth Hormone Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Human Growth Hormone Sales Value, 2019-2030
5.6.2 Asia Pacific Human Growth Hormone Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Human Growth Hormone Sales Value, 2019-2030
5.7.2 South America Human Growth Hormone Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Human Growth Hormone Sales Value, 2019-2030
5.8.2 Middle East & Africa Human Growth Hormone Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Human Growth Hormone Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Human Growth Hormone Sales Value
6.2.1 Key Countries/Regions Human Growth Hormone Sales Value, 2019-2030
6.2.2 Key Countries/Regions Human Growth Hormone Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Human Growth Hormone Sales Value, 2019-2030
6.3.2 United States Human Growth Hormone Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Human Growth Hormone Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Human Growth Hormone Sales Value, 2019-2030
6.4.2 Europe Human Growth Hormone Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Human Growth Hormone Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Human Growth Hormone Sales Value, 2019-2030
6.5.2 China Human Growth Hormone Sales Value by Type (%), 2023 VS 2030
6.5.3 China Human Growth Hormone Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Human Growth Hormone Sales Value, 2019-2030
6.6.2 Japan Human Growth Hormone Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Human Growth Hormone Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Human Growth Hormone Sales Value, 2019-2030
6.7.2 South Korea Human Growth Hormone Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Human Growth Hormone Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Human Growth Hormone Sales Value, 2019-2030
6.8.2 Southeast Asia Human Growth Hormone Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Human Growth Hormone Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Human Growth Hormone Sales Value, 2019-2030
6.9.2 India Human Growth Hormone Sales Value by Type (%), 2023 VS 2030
6.9.3 India Human Growth Hormone Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Novo Nordisk
7.1.1 Novo Nordisk Company Information
7.1.2 Novo Nordisk Introduction and Business Overview
7.1.3 Novo Nordisk Human Growth Hormone Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Novo Nordisk Human Growth Hormone Product Offerings
7.1.5 Novo Nordisk Recent Development
7.2 Pfizer
7.2.1 Pfizer Company Information
7.2.2 Pfizer Introduction and Business Overview
7.2.3 Pfizer Human Growth Hormone Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Pfizer Human Growth Hormone Product Offerings
7.2.5 Pfizer Recent Development
7.3 Eli Lilly
7.3.1 Eli Lilly Company Information
7.3.2 Eli Lilly Introduction and Business Overview
7.3.3 Eli Lilly Human Growth Hormone Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Eli Lilly Human Growth Hormone Product Offerings
7.3.5 Eli Lilly Recent Development
7.4 Merck Serono
7.4.1 Merck Serono Company Information
7.4.2 Merck Serono Introduction and Business Overview
7.4.3 Merck Serono Human Growth Hormone Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Merck Serono Human Growth Hormone Product Offerings
7.4.5 Merck Serono Recent Development
7.5 F. Hoffmann-La Roche
7.5.1 F. Hoffmann-La Roche Company Information
7.5.2 F. Hoffmann-La Roche Introduction and Business Overview
7.5.3 F. Hoffmann-La Roche Human Growth Hormone Sales, Revenue and Gross Margin (2019-2024)
7.5.4 F. Hoffmann-La Roche Human Growth Hormone Product Offerings
7.5.5 F. Hoffmann-La Roche Recent Development
7.6 Ferring Pharmaceuticals
7.6.1 Ferring Pharmaceuticals Company Information
7.6.2 Ferring Pharmaceuticals Introduction and Business Overview
7.6.3 Ferring Pharmaceuticals Human Growth Hormone Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Ferring Pharmaceuticals Human Growth Hormone Product Offerings
7.6.5 Ferring Pharmaceuticals Recent Development
7.7 GeneScience Pharmaceuticals
7.7.1 GeneScience Pharmaceuticals Company Information
7.7.2 GeneScience Pharmaceuticals Introduction and Business Overview
7.7.3 GeneScience Pharmaceuticals Human Growth Hormone Sales, Revenue and Gross Margin (2019-2024)
7.7.4 GeneScience Pharmaceuticals Human Growth Hormone Product Offerings
7.7.5 GeneScience Pharmaceuticals Recent Development
7.8 Ipsen
7.8.1 Ipsen Company Information
7.8.2 Ipsen Introduction and Business Overview
7.8.3 Ipsen Human Growth Hormone Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Ipsen Human Growth Hormone Product Offerings
7.8.5 Ipsen Recent Development
7.9 LG Life Sciences
7.9.1 LG Life Sciences Company Information
7.9.2 LG Life Sciences Introduction and Business Overview
7.9.3 LG Life Sciences Human Growth Hormone Sales, Revenue and Gross Margin (2019-2024)
7.9.4 LG Life Sciences Human Growth Hormone Product Offerings
7.9.5 LG Life Sciences Recent Development
7.10 Sandoz International
7.10.1 Sandoz International Company Information
7.10.2 Sandoz International Introduction and Business Overview
7.10.3 Sandoz International Human Growth Hormone Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Sandoz International Human Growth Hormone Product Offerings
7.10.5 Sandoz International Recent Development
7.11 Anhui Anke Biotechnology
7.11.1 Anhui Anke Biotechnology Company Information
7.11.2 Anhui Anke Biotechnology Introduction and Business Overview
7.11.3 Anhui Anke Biotechnology Human Growth Hormone Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Anhui Anke Biotechnology Human Growth Hormone Product Offerings
7.11.5 Anhui Anke Biotechnology Recent Development
8 Industry Chain Analysis
8.1 Human Growth Hormone Industrial Chain
8.2 Human Growth Hormone Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Human Growth Hormone Sales Model
8.5.2 Sales Channel
8.5.3 Human Growth Hormone Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Novo Nordisk
Pfizer
Eli Lilly
Merck Serono
F. Hoffmann-La Roche
Ferring Pharmaceuticals
GeneScience Pharmaceuticals
Ipsen
LG Life Sciences
Sandoz International
Anhui Anke Biotechnology

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.